Access expanding for experimental weight loss drug

Drugmaker Eli Lilly says it is expanding access to its experimental weight loss drug, retatrutide, which has not been approved yet by the FDA. The company says obese patients taking the drug in clinical trials lost between 73 and 85 pounds over two years. Dr. Rachel Pessah Pollack discusses what we know about its safet

A breast cancer surgeon explains how GLP-1 drugs like Ozempic and Wegovy may lower cancer recurrence risk by reducing BMI, estrogen and inflammation.

J. Vespa/WireImage Remember the Titans actor Ethan Suplee slammed a mistake many GLP-1 users make, using his remarkable weight-loss journey as a reference point. Suplee peaked at 536 pounds in 2001, then lost a mind-boggling 300 pounds through diet and lifestyle changes. “As a kid, I wanted a magical diet drug so badly

Jaime says TikTok taught her how to buy and inject black market peptides. Months later, she had lost 17kg.

"Employers are dropping coverage for GLP-1 drugs like Wegovy and Zepbound in greater numbers, nudging more patients to direct-to-consumer prescriptions."

As employers drop coverage for GLP-1 drugs like Wegovy and Zepbound, retail giants are competing to lock in customers through direct-to-consumer programs

Doctors are considering weight-loss drugs for the autistic man, who has been kept in secure care for two decades.